Archives

Wald: Context Intelligence Company Secures $4 Million (Seed)

By Amit Chowdhry ● Dec 13, 2024

Context intelligence company Wald has unveiled its contextual AI and data loss protection platform and announced it had closed a $4 million seed round. The company’s seed round investors include Inventus Capital, Entrada Ventures, and several prominent angel investors, including executives from cybersecurity companies like Palo Alto Networks, Fortinet, and HackerOne.

EVgo: $1.25 Billion Guaranteed Loan Facility From DOE Closed

By Amit Chowdhry ● Dec 13, 2024

EVgo announced the closing of its $1.25 billion guaranteed loan facility from the U.S. Department of Energy (DOE) Loan Programs Office (LPO) under its Title 17 Clean Energy Financing Program to support EVgo’s forthcoming efforts to build convenient and reliable public charging infrastructure for electric vehicles (EVs) with the construction of 7,500 new fast charging stalls nationwide. This buildout brings EVgo’s total owned and operated network to at least 10,000 fast-charging stalls, enabling the company to triple its network footprint by 2029.

RELEX Solutions Raises Funding From Blackstone and TCV

By Amit Chowdhry ● Dec 13, 2024

RELEX Solutions - a provider of unified supply chain and retail planning solutions - announced that funds managed by Blackstone Growth (Blackstone’s growth equity investing business) and TCV (a leading investment firm focused on investing in global, category-defining technology companies) have increased their investment in RELEX. The deal represents an exit for original RELEX investor Summit Partners, which initially invested in the company in 2015. Blackstone and TCV first invested in RELEX in 2022 and 2019, respectively.

Hyro: Healthcare-Focused Voice And Chat AI Company Raises Funding (Series B Extension)

By Amit Chowdhry ● Dec 13, 2024

Hyro, a leader in voice and chat artificial intelligence (AI) for healthcare, announced that it had finalized an extension to its Series B funding round led by Healthier Capital, joining previous investors, including Macquarie Capital, Liberty Mutual, Twilio, and Black Opal Ventures. This brings the company's total funding to $50 million.

Zest AI: $200 Million Growth Investment Raised From Insight Partners

By Amit Chowdhry ● Dec 13, 2024

Zest AI, a leader in AI-based lending technology, announced a $200 million growth investment from global software investor Insight Partners to support the company's next transformation phase. This growth capital will enable Zest AI to double down on its current product portfolio, continuing to advance fraud protection and generative AI.

Concentro: Clean Energy Financing Company Secures $3 Million (Seed)

By Amit Chowdhry ● Dec 13, 2024

Concentro - a clean energy financing platform - announced it closed a seed round of $3 million in an oversubscribed deal led by firstminute Capital, with participation from Silence VC, LifeX, Plug & Play, & Avesta Fund. Other participants include existing investors J Ventures, Contour Venture Partners, & Dorm Room Fund, and various angels and VC scout networks.

J.F. Lehman & Company: $2.2 Billion Fund VI Closed

By Amit Chowdhry ● Dec 13, 2024

J.F. Lehman & Company (JFLCO) - a leading middle-market private equity firm focused exclusively on the aerospace, defense, maritime, government, and environmental sectors - announced the successful closing of its latest flagship fund, JFL Equity Investors VI, L.P. and affiliated investments vehicles (Fund VI). And at $2.23 billion, the offering marks the largest in the firm's 33-year history and was meaningfully oversubscribed relative to its $1.6 billion target.

Noema Pharma: Biotech Company Closes Series B At About $147 Million

By Amit Chowdhry ● Dec 13, 2024

Noema Pharma - a clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders - announced the closing of a Series B extension financing round with an investment from EQT Life Sciences, bringing the total capital raised in the round to CHF 130 million (about $147 million). With an investment in Noema Pharma, EQT Life Sciences joins the syndicate of previous Series B investors, including Forbion, Jeito Capital, Sofinnova Partners, Gilde Healthcare, Polaris Partners, Invus, and UPMC Enterprises.

nChroma Bio: $75 Million Raised To Advance Genetic Medicines

By Amit Chowdhry ● Dec 13, 2024

Chroma Medicine and Nvelop Therapeutics announced their merger and subsequent launch of nChroma Bio, which will redefine the future of genetic medicines. nChroma combines potent epigenetic editing with non-viral, programmable delivery to address key limitations in the field and expand the scope of treatable diseases. The merger will result in an industry-leading company with a deeply experienced team. Jeff Walsh will serve as nChroma’s CEO, and Jeff Marrazzo will serve as its Chairman of the Board.

Veradermics: $75 Million (Series B) Raised To Develop Therapeutics For Common Dermatologic Conditions

By Amit Chowdhry ● Dec 13, 2024

Veradermics - a late clinical-stage aesthetics and dermatology-focused biopharmaceutical company developing first-in-class therapeutics for common dermatologic conditions - announced the closing of a $75 million Series B financing. The financing was led by Suvretta Capital Management and included new investors Longitude Capital, Surveyor Capital (a Citadel company), Osage University Partners, and PhiFund. Existing investors, JW Childs Associates, Connecticut Innovations, and Vlad Coric, MD, also participated in this round.

Current: Consumer Fintech Banking Platform Raises $200 Million In New Capital

By Amit Chowdhry ● Dec 13, 2024

Current - a leading consumer fintech banking platform transforming financial access for everyday Americans - announced notable growth in 2024, including an over 90% increase in revenue. And following this record year, the company has secured $200 million in new capital to accelerate growth and fast-track profitability next year. This funding round included continued support from existing investors Andreessen Horowitz, Wellington Management, and Avenir, with new participation from General Catalyst and Cross River.

Chordline Health: Interview With CEO Billie Jo Nutter About The Collaborative Care Company

By Amit Chowdhry ● Dec 13, 2024

Chordline Health makes managing your patient population easier with our all-in-one platform ACUITYnxt, prioritizing data-driven decisions and collaborative care coordination. Pulse 2.0 interviewed Chordline Health CEO Billie Jo Nutter to learn more about the company.

Biomemory: DNA Storage Company Raises $18 Million (Series A)

By Amit Chowdhry ● Dec 13, 2024

DNA data storage company Biomemory announced it has raised $18 million in Series A funding. The funding round was led by Crédit Mutuel Innovation, with participation from the historical investor of the French Tech Seed fund managed on behalf of the French State by Bpifrance within the scope of France 2030 and new investors Blast, the Deep Tech 2030 fund managed on behalf of the state by Bpifrance as part of France 2030, Paris Business Angels, Sorbonne Venture, Adnexus, Prunay, Next Sequence, and Accelerem.

TruVideo: AI-Based Video And Messaging Company Raises $40 Million

By Amit Chowdhry ● Dec 13, 2024

TruVideo - a leader in AI- and AR-driven communication technology for the transportation industry - announced that it has secured a $40 million minority growth investment from TZP Growth Equity.

Tasca Therapeutics: Drug Discovery Platform Secures $52 Million (Series A)

By Amit Chowdhry ● Dec 13, 2024

Tasca Therapeutics, a biotechnology company that utilizes a unique drug discovery platform that identifies and maps novel lipid-binding pockets on proteins to develop new medicines to treat human diseases, announced a $52 million Series A financing, co-led by Regeneron Ventures and Cure Ventures, with participation from Invus Group. This funding round will advance Tasca’s novel drug discovery platform, progress its lead program, CP-383, into Phase 1/2 clinical proof-of-concept studies, and expand its drug candidate pipeline.

Aampe: AI Agent Personalization Company Raises $18 Million (Series A)

By Amit Chowdhry ● Dec 13, 2024

Aampe announced it has deployed over 100 million intelligent agents into consumer applications across four continents. The company also announced $18 million in Series A funding led by Theory Ventures, which brought Aampe’s total funding to $27.3 million to accelerate the adoption of its agentic infrastructure. Z47 is also participating in the round.

Next Sense: Smart Building Platform Company Raises €11.5 Million (Series A)

By Amit Chowdhry ● Dec 13, 2024

Next Sense - a leading provider of Smart Building Platform SaaS solutions - announced the closing of an €11.5 million Series A investment round. The funding round was co-led by ABP and ETF Partners, with additional participation from existing shareholders Edge, SHAPE Capital, and Timeless Investments.

BITKRAFT Ventures Receives Minority Fund Investment From Blue Owl

By Amit Chowdhry ● Dec 13, 2024

BITKRAFT Ventures announced a passive minority investment from a fund managed by Blue Owl’s GP Strategic Capital platform. This funding enables BITKRAFT to further expand its operating capabilities and expand its investment platform, which includes more than $1 billion in assets under management and six funds covering early-stage venture, growth stage venture, and Web3/Crypto. Blue Owl’s GP Strategic Capital platform provides minority equity and financing solutions to private capital managers.

Blackstone: Over $1 Billion To Drive JSSI’s Growth

By Amit Chowdhry ● Dec 13, 2024

Blackstone Credit & Insurance and Jet Support Services (JSSI) announced over $1 billion in new financings to support the recapitalization of JSSI, the world’s largest independent provider of hourly cost maintenance programs for business aircraft engines, auxiliary power units, and airframes. The funds managed by Blackstone have now provided over $1.8 billion in debt financing and investment in common equity in a series of financings for JSSI, a portfolio company of leading private equity firms GTCR and Genstar Capital.

Ambrosia Biosciences: Drug Discovery Company Secures $25 Million (Series A)

By Amit Chowdhry ● Dec 13, 2024

Ambrosia Biosciences announced the second closing of its Series A financing. Merck, known as MSD outside the US and Canada, led this funding closing with additional participation from existing investors BVF Partners and Boulder Ventures. This capital brings Ambrosia's total Series A funding to $25 million.

Nexus W2V: $140 Million Raised And Construction Of Flagship RNG Facility In Indiana Revealed

By Amit Chowdhry ● Dec 13, 2024

Nexus W2V - a leading developer of waste-to-value infrastructure projects - announced the closing of an anchor $75 million structured equity commitment from Orion Infrastructure Capital (OIC). And with additional investment from Nexus Holdings, Khasma Capital, and debt financing from Ameris Bank.

Qnovia: $16 Million (Series B) Closed To Develop Proprietary Inhalation Device Technologies

By Amit Chowdhry ● Dec 13, 2024

Pharmaceutical company Qnovia announced that the U.S. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application for the RespiRx Nicotine Inhaler (QN-01), a prescription inhaled smoking cessation medicine. The company also announced that it raised $16 million in Series B funding, led by Blue Ledge Capital, Evolution VC Partners, Vice Ventures, and Gaingels.

DorothyAI: Interview With President Sharon Shofner-Meyer About The AI-Based IP Management Solutions Company

By Amit Chowdhry ● Dec 13, 2024

DorothyAI is a pioneer in AI-driven intellectual property management solutions. Pulse 2.0 interviewed DorothyAI President Sharon Shofner-Meyer, J.D., to learn more about the firm.

JA Moody Signs Partnership With PE Firm New Heritage Capital

By Amit Chowdhry ● Dec 13, 2024

JA Moody - a premier maritime supplier of fluid control valves, actuators, strainers, parts, and services to the US Navy and Commercial Marine industry - announced a strategic partnership and investment from New Heritage Capital, a Boston-based private equity firm specializing in founder-owned businesses.

AQEMIA: Drug Discovery Pipeline Company Raises $38 Million

By Amit Chowdhry ● Dec 13, 2024

AQEMIA, a biotechnology company that teaches atomic-scale physics to a generative AI (GenAI) for inventing new medicines, announced two significant milestones: $100 million in total funding and the beginning of a global expansion, starting with London (United Kingdom). This new round is led by Cathay Innovation, followed by historical investors Wendel, Bpifrance Large Venture, Eurazeo, and Elaia.

Leyline Renewable Capital: $140 Million Raised From Keystone And Public University Foundation

By Amit Chowdhry ● Dec 13, 2024

Leyline Renewable Capital, a leading provider of debt capital solutions for renewable energy developers, announced that it has secured a total of $140 million in capital from Keystone National Group and a large public university foundation.

Gavan: $8 Million (Series A) Raised To Commercialize Plant-Based Fat

By Amit Chowdhry ● Dec 13, 2024

Food technology company Gavan Technologies has raised an $8 million Series A. This new funding round will enable Gavan to enter the European food market with its plant protein-based fat solution, Fatrix. MoreVC led the round, which also included participation from Lever VC, EIT Food, and DarkBoot Group.

Ask Sage: $17 Million (Series A) Raised To Build GenAI Platforms For Government And Commercial Sectors

By Amit Chowdhry ● Dec 13, 2024

Ask Sage - a leading Generative AI (GenAI) platform for government and commercial sectors - announced it has raised $17 million in a Series A funding round. This latest funding was led by Sapphire Ventures, with participation from Mucker Capital. This funding will enable Ask Sage to expand its Generative AI offerings, accelerate growth, and strategically expand its workforce.

RapidCanvas: $16 Million Raised For Putting AI Agents To Work

By Amit Chowdhry ● Dec 13, 2024

RapidCanvas, a company democratizing AI-driven business transformation, announced a $16 million funding round for its AI agents. These agents, powered by large language models (LLMs), can automate up to 75% of complex tasks traditionally performed by data scientists and engineers. They can process vast amounts of information, identify patterns, and make decisions, replicating many human skills.

Angitia Biopharmaceuticals: $120 Million (Series C) Raised To Develop Therapeutics For Serious Musculoskeletal Diseases

By Amit Chowdhry ● Dec 13, 2024

Angitia Biopharmaceuticals - a clinical-stage biotechnology company focused on discovering and developing innovative therapeutics for serious musculoskeletal diseases - announced the closing of a $120 million Series C financing round. Bain Capital Life Sciences led the funding, with participation from new investor Janus Henderson and existing investors OrbiMed, 3H Health Investment, Yonghua Capital, Legend Capital, and Elikon Venture. This funding will support Angitia’s robust pipeline of novel, differentiated treatments for serious musculoskeletal diseases.